Journal article
β-Secretase 1’s Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice
Frontiers in cellular neuroscience, Vol.9(2016), pp.498-498
01/08/2016
DOI: 10.3389/fncel.2015.00498
PMCID: PMC4705306
PMID: 26778963
Abstract
β-site APP cleaving enzyme 1 (BACE1) initiates APP cleavage, which has been reported to be an inducer of tau pathology by altering proteasome functions in Alzheimer’s disease (AD). However, the exact relationship between BACE1 and PHF (Paired Helical Filaments) formation is not clear. In this study, we confirm that BACE1 and Hsc70 are upregulated in the brains of AD patients, and we demonstrate that both proteins show enhanced expression in lipid rafts from AD-affected triple transgenic mouse brains. BACE1 targeting increased Hsc70 levels in the membrane and cytoplasm fractions and downregulated Hsp90 and CHIP in the nucleus in the hippocampi of 3xTg-AD mice. However, these observations occurred in a proteasome-independent manner
in vitro
. The BACE1miR-induced reduction of soluble hyperphosphorylated tau was associated with a decrease in MAPK activity. However, the BACE1 RNAi-mediated reduction of hyperphosphorylated tau was only blocked by 3-MA (3-methyladenine)
in vitro
, and it resulted in the increase of Hsc70 and LAMP2 in lipid rafts from hippocampi of 3xTg-AD mice, and upregulation of survival and homeostasis signaling. In summary, our findings suggest that BACE1 silencing neuroprotects reducing soluble hyperphosphorylated tau, modulating certain autophagy-related proteins in aged 3xTg-AD mice.
Details
- Title: Subtitle
- β-Secretase 1’s Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice
- Creators
- Diego Piedrahita - Cellular and Molecular Neurobiology Area, Viral Vector Core and Gene Therapy, University of AntioquiaJohn Fredy Castro-Alvarez - Cellular and Molecular Neurobiology Area, Viral Vector Core and Gene Therapy, University of AntioquiaRyan L Boudreau - Internal Medicine, University of IowaAndres Villegas-Lanau - Neurobank, Neuroscience Group of Antioquia, Faculty of Medicine, SIU, University of AntioquiaKenneth S Kosik - Department of Molecular Cellular Developmental Biology, Neuroscience Research Institute, University of California Santa BarbaraJuan Carlos Gallego-Gomez - Cellular and Molecular Neurobiology Area, Viral Vector Core and Gene Therapy, University of AntioquiaGloria Patricia Cardona-Gómez - Cellular and Molecular Neurobiology Area, Viral Vector Core and Gene Therapy, University of Antioquia
- Resource Type
- Journal article
- Publication Details
- Frontiers in cellular neuroscience, Vol.9(2016), pp.498-498
- DOI
- 10.3389/fncel.2015.00498
- PMID
- 26778963
- PMCID
- PMC4705306
- NLM abbreviation
- Front Cell Neurosci
- ISSN
- 1662-5102
- eISSN
- 1662-5102
- Publisher
- Frontiers Media S.A
- Grant note
- AG029802-01 / Fogarty International Center 111554531478; 111551928905 / Administrative Department of Science, Technology and Innovation
- Language
- English
- Date published
- 01/08/2016
- Academic Unit
- Iowa Neuroscience Institute; Cardiovascular Medicine; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9984065391202771
Metrics
16 Record Views